The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles

Front Immunol. 2022 Sep 2:13:953917. doi: 10.3389/fimmu.2022.953917. eCollection 2022.

Abstract

Sharks and other cartilaginous fish produce new antigen receptor (IgNAR) antibodies, as key part of their humoral immune response and are the phylogenetically oldest living organisms that possess an immunoglobulin (Ig)-based adaptive immune system. IgNAR antibodies are naturally occurring heavy-chain-only antibodies, that recognize antigens with their single domain variable regions (VNARs). In this study, we structurally and biophysically elucidate the effect of antibody humanization of a previously published spiny dogfish VNAR (parent E06), which binds with high affinity to the human serum albumin (HSA). We analyze different humanization variants together with the parental E06 VNAR and the human Vκ1 light chain germline DPK9 antibody to characterize the influence of point mutations in the framework and the antigen binding site on the specificity of VNARs as reported by Kovalenko et al. We find substantially higher flexibility in the humanized variants, reflected in a broader conformational space and a higher conformational entropy, as well as population shifts of the dominant binding site ensembles in solution. A further variant, in which some mutations are reverted, largely restores the conformational stability and the dominant binding minimum of the parent E06. We also identify differences in surface hydrophobicity between the human Vκ1 light chain germline DPK9 antibody, the parent VNAR E06 and the humanized variants. Additional simulations of VNAR-HSA complexes of the parent E06 VNAR and a humanized variant reveal that the parent VNAR features a substantially stronger network of stabilizing interactions. Thus, we conclude that a structural and dynamic understanding of the VNAR binding site upon humanization is a key aspect in antibody humanization.

Keywords: VNAR; humanization; hydrophobicity; molecular dynamics simulations; novel biotherapeutic formats; shark.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies
  • Antigens
  • Binding Sites
  • Humans
  • Immunoglobulin Heavy Chains
  • Receptors, Antigen / genetics
  • Serum Albumin, Human
  • Sharks* / genetics

Substances

  • Antibodies
  • Antigens
  • Immunoglobulin Heavy Chains
  • Receptors, Antigen
  • Serum Albumin, Human